Sponsors (2)
The bill tightens import and enforcement rules to improve consumer safety and manufacturing integrity, but it raises compliance costs and legal risks for small manufacturers and may reduce product availability or raise prices for some consumers.
Consumers — especially low-income individuals and patients with chronic conditions — will be less likely to buy products mislabeled as dietary supplements, reducing exposure to unsafe or undeclared ingredients.
Consumers and taxpayers will face fewer harmful imported supplements because authorities can refuse noncompliant products at the border, reducing the entry of unsafe products into the U.S. market.
Small-business owners and consumers will benefit from stronger manufacturing integrity because suppliers who use debarred persons face seizure risk, discouraging use of banned individuals in the supply chain.
Small supplement manufacturers and importers will face higher compliance costs and greater risk of product seizures, increasing business expenses and possibly threatening smaller firms' viability.
Consumers — particularly low-income individuals — may see reduced product variety and higher prices if retailers withdraw borderline products to avoid enforcement risk.
Small-business owners and manufacturers face risk of mistaken enforcement because ambiguity over what qualifies as a 'dietary supplement' could trigger costly legal disputes and seizures.
Based on analysis of 2 sections of legislative text.
Makes it illegal to market non‑qualifying products as dietary supplements or to sell supplements made with debarred individuals, and allows FDA to seize or refuse such imports.
Introduced February 5, 2026 by Richard Joseph Durbin · Last progress February 5, 2026
Adds two new prohibitions to the Federal Food, Drug, and Cosmetic Act that target certain dietary-supplement products and supply-chain actors: (1) it bans introducing into interstate commerce any product sold as a "dietary supplement" that does not meet the statutory definition of a dietary supplement, and (2) it bans introducing dietary supplements into interstate commerce if those supplements were prepared, packed, or held with the assistance or at the direction of a person who has been debarred. The bill also makes such products subject to U.S. import refusal and to seizure under existing FDA enforcement authorities.